ACE2 and COVID-19: To assess the expression status of the differentially secreted cytokines upon ACE2 overexpression and treatment with nivolumab, single cell (sc) RNA-seq data from PBMNCs obtained from a cohort of 425,398 single cells from COVID-19 patients [54] were examined using CZ CELLxGENE Discover.